The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment.
The global Point-of-care Infectious Disease Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.
However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Point-of-care Infectious Disease Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-of-care Infectious Disease Diagnostics.
Report Scope
The Point-of-care Infectious Disease Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Point-of-care Infectious Disease Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point-of-care Infectious Disease Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List)
- Thermo Fisher Scientific
- Abbott
- Calypte Biomedical
- Chembio Diagnostic Systems
- Meridian Bioscience
- MedMira
- Trinity Biotech
- Sekisui Diagnostics
- OraSure Technologies
- Quidel
Segment by Type
- HIV POC
- Clostridium Difficile POC
- HBV POC
- Respiratory Syncytial Virus POC
- HPV POC
- Influenza/Flu POC
- HCV POC
- MRSA POC
- TB and Drug-Resistant TB POC
Segment by Application
- Hospitals
- Clinics
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point-of-care Infectious Disease Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 HIV POC
1.2.3 Clostridium Difficile POC
1.2.4 HBV POC
1.2.5 Respiratory Syncytial Virus POC
1.2.6 HPV POC
1.2.7 Influenza/Flu POC
1.2.8 HCV POC
1.2.9 MRSA POC
1.2.10 TB and Drug-Resistant TB POC
1.3 Market by Application
1.3.1 Global Point-of-care Infectious Disease Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Assisted Living Healthcare Facilities
1.3.6 Laboratories
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point-of-care Infectious Disease Diagnostics Market Perspective (2019-2030)
2.2 Point-of-care Infectious Disease Diagnostics Growth Trends by Region
2.2.1 Global Point-of-care Infectious Disease Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Point-of-care Infectious Disease Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Point-of-care Infectious Disease Diagnostics Market Dynamics
2.3.1 Point-of-care Infectious Disease Diagnostics Industry Trends
2.3.2 Point-of-care Infectious Disease Diagnostics Market Drivers
2.3.3 Point-of-care Infectious Disease Diagnostics Market Challenges
2.3.4 Point-of-care Infectious Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue
3.1.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Point-of-care Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point-of-care Infectious Disease Diagnostics Revenue
3.4 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio
3.4.1 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Infectious Disease Diagnostics Revenue in 2023
3.5 Point-of-care Infectious Disease Diagnostics Key Players Head office and Area Served
3.6 Key Players Point-of-care Infectious Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Point-of-care Infectious Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-care Infectious Disease Diagnostics Breakdown Data by Type
4.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2025-2030)
5 Point-of-care Infectious Disease Diagnostics Breakdown Data by Application
5.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Point-of-care Infectious Disease Diagnostics Market Size (2019-2030)
6.2 North America Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024)
6.4 North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point-of-care Infectious Disease Diagnostics Market Size (2019-2030)
7.2 Europe Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024)
7.4 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size (2019-2030)
9.2 Latin America Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Introduction
11.1.4 Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Point-of-care Infectious Disease Diagnostics Introduction
11.2.4 Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Calypte Biomedical
11.3.1 Calypte Biomedical Company Detail
11.3.2 Calypte Biomedical Business Overview
11.3.3 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Introduction
11.3.4 Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
11.3.5 Calypte Biomedical Recent Development
11.4 Chembio Diagnostic Systems
11.4.1 Chembio Diagnostic Systems Company Detail
11.4.2 Chembio Diagnostic Systems Business Overview
11.4.3 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Introduction
11.4.4 Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
11.4.5 Chembio Diagnostic Systems Recent Development
11.5 Meridian Bioscience
11.5.1 Meridian Bioscience Company Detail
11.5.2 Meridian Bioscience Business Overview
11.5.3 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Introduction
11.5.4 Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
11.5.5 Meridian Bioscience Recent Development
11.6 MedMira
11.6.1 MedMira Company Detail
11.6.2 MedMira Business Overview
11.6.3 MedMira Point-of-care Infectious Disease Diagnostics Introduction
11.6.4 MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
11.6.5 MedMira Recent Development
11.7 Trinity Biotech
11.7.1 Trinity Biotech Company Detail
11.7.2 Trinity Biotech Business Overview
11.7.3 Trinity Biotech Point-of-care Infectious Disease Diagnostics Introduction
11.7.4 Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
11.7.5 Trinity Biotech Recent Development
11.8 Sekisui Diagnostics
11.8.1 Sekisui Diagnostics Company Detail
11.8.2 Sekisui Diagnostics Business Overview
11.8.3 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Introduction
11.8.4 Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
11.8.5 Sekisui Diagnostics Recent Development
11.9 OraSure Technologies
11.9.1 OraSure Technologies Company Detail
11.9.2 OraSure Technologies Business Overview
11.9.3 OraSure Technologies Point-of-care Infectious Disease Diagnostics Introduction
11.9.4 OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
11.9.5 OraSure Technologies Recent Development
11.10 Quidel
11.10.1 Quidel Company Detail
11.10.2 Quidel Business Overview
11.10.3 Quidel Point-of-care Infectious Disease Diagnostics Introduction
11.10.4 Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2019-2024)
11.10.5 Quidel Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
